Skip to main content

Advertisement

SpringerLink
Log in

miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM

  • Research Article
  • Published:
Tumor Biology

Abstract

Invasion and migration of glioblastoma multiforme (GBM) is a multistep process and an important phenotype that causes this disease to invade surrounding tissues in the brain. Recent studies have highlighted that miRNAs play a pivotal role in controlling GBM cell plasticity. In this report, we used wound healing and transwell assays to identify a novel role of miR-139-5p in inhibition of GBM cell migration and invasion. Bioinformatics coupled with luciferase and Western blot assays also revealed that miR-139-5p inhibited expression of ZEB1 and ZEB2, which are master regulators of tumor metastasis. MiR-139-5p specifically interacts with the 3′-UTR regions of ZEB1 and ZEB2, attenuating their expression in GBM cells. To corroborate this finding, we rescued ZEB1 and ZEB2 expression and found partial but significant increases in miR-139-5p-suppressed invasion of GBM cells. The biological relevance of our study was validated by analyzing levels of miR-139-5p in GBM tissue. We found that its expression significantly downregulated compared to normal tissue and shorter overall survival rates in patients with lower miR-139-5p expression. These results confirm that miR-139-5p suppresses GBM migration and invasion and highlight its potential as a biomarker and therapeutic target for treating GBM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004;70:217–28.

    Article  PubMed  Google Scholar 

  2. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2:494–503. quiz 491 p following 516.

    Article  PubMed  Google Scholar 

  3. McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer. 2003;98:1745–8.

    Article  PubMed  Google Scholar 

  4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

    Article  CAS  PubMed  Google Scholar 

  5. Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 1845;2014:255–65.

    Google Scholar 

  6. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, et al. Cathepsin b expression and localization in glioma progression and invasion. Cancer Res. 1994;54:6027–31.

    CAS  PubMed  Google Scholar 

  7. Obara S, Nakata M, Takeshima H, Kuratsu J, Maruyama I, Kitajima I. Inhibition of migration of human glioblastoma cells by cerivastatin in association with focal adhesion kinase (FAK). Cancer Lett. 2002;185:153–61.

    Article  CAS  PubMed  Google Scholar 

  8. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 1995;55:2752–5.

    CAS  PubMed  Google Scholar 

  9. Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013;5:1196–212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep. 2010;11:670–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vandewalle C, Van Roy F, Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci. 2009;66:773–87.

    Article  CAS  PubMed  Google Scholar 

  12. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene. 2007;26:6979–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 2008;68:537–44.

    Article  CAS  PubMed  Google Scholar 

  14. Moller HG, Rasmussen AP, Andersen HH, Johnsen KB, Henriksen M, Duroux M. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol. 2013;47:131–44.

    Article  CAS  PubMed  Google Scholar 

  15. Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, et al. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology. 2011;141:2076–87.

    Article  CAS  PubMed  Google Scholar 

  16. Liu R, Yang M, Meng Y, Liao J, Sheng J, Pu Y, et al. Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma. PLoS One. 2013;8:e77068.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology. 2011;140:322–31.

    Article  CAS  PubMed  Google Scholar 

  18. Gu W, Li X, Wang J. Mir-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Oncol Rep. 2014;31:397–404.

    CAS  PubMed  Google Scholar 

  19. Li RY, Chen LC, Zhang HY, Du WZ, Feng Y, Wang HB, et al. MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. CNS Neurosci Ther. 2013;19:477–83.

    Article  CAS  PubMed  Google Scholar 

  20. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A. 2010;107:20828–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–22.

    Article  CAS  PubMed  Google Scholar 

  22. Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, et al. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein Cell 2014.

  23. Krishnan K, Steptoe AL, Martin HC, Pattabiraman DR, Nones K, Waddell N, et al. Cloonan N: miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA. 2013;19:1767–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kahlert UD, Nikkhah G, Maciaczyk J. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett. 2013;331:131–8.

    Article  CAS  PubMed  Google Scholar 

  25. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682–8.

    Article  CAS  PubMed  Google Scholar 

  26. Valastyan S, Benaich N, Chang A, Reinhardt F, Weinberg RA. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev. 2009;23:2592–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009;137:1032–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Valastyan S, Weinberg RA. MicroRNAs: crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle. 2009;8:3506–12.

    Article  CAS  PubMed  Google Scholar 

  29. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029–33.

    Article  CAS  PubMed  Google Scholar 

  30. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28:5369–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han L, Jia ZF, et al. MiR-221 and miR-222 target puma to induce cell survival in glioblastoma. Mol Cancer. 2010;9:229.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zhang J, Han L, Ge Y, Zhou X, Zhang A, Zhang C, et al. miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int J Oncol. 2010;36:913–20.

    CAS  PubMed  Google Scholar 

  33. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, et al. MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008;68:3566–72.

    Article  CAS  PubMed  Google Scholar 

  34. Wu DG, Wang YY, Fan LG, Luo H, Han B, Sun LH, et al. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J (Engl). 2011;124:2616–21.

    CAS  Google Scholar 

  35. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69:7569–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Luan S, Sun L, Huang F. MicroRNA-34a: A novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res. 2010;41:67–74.

    Article  CAS  PubMed  Google Scholar 

  37. Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, Sander C, et al. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One. 2012;7:e33844.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting micrornas. Nat Cell Biol. 2009;11:1487–95.

    Article  CAS  PubMed  Google Scholar 

Download references

Author contributions

S.Y., L.W., and Y.L. conceived and designed the experiments; S.Y., L.W., H.Z., Y.M., Y.L., H.S., Y.J., and W.Z. performed the experiments; S.Y., L.W., H.Z., Y.M., Y.L., and A.L. analyzed the data; Y.G., P.C., G.L., L.W., and Q.Z. contributed reagents/materials/analysis tools; S.Y., L.W., H.Z., and Y.L. wrote the paper.

Conflicts of interest

None

Author information

Author notes

    Authors and Affiliations

    1. Department of Neurosurgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou Central Hospital, 195 Tongbai Road, Zhongyuan District, Zhengzhou, Henan, 450000, China

      Sihai Yue, Lihua Wang, Hui Zhang, Youhui Min, Yongli Lou, Hongshan Sun, Yu Jiang, Wenjin Zhang, Aming Liang, Yongkun Guo, Ping Chen, Guowei Lv, Liuxiang Wang, Qinghua Zong & Yong Li

    Authors
    1. Sihai Yue
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Lihua Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Hui Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Youhui Min
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Yongli Lou
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Hongshan Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Yu Jiang
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Wenjin Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Aming Liang
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Yongkun Guo
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Ping Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Guowei Lv
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Liuxiang Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Qinghua Zong
      View author publications

      You can also search for this author in PubMed Google Scholar

    15. Yong Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Yong Li.

    Additional information

    Sihai Yue and Lihua Wang contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Yue, S., Wang, L., Zhang, H. et al. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. Tumor Biol. 36, 6741–6749 (2015). https://doi.org/10.1007/s13277-015-3372-8

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s13277-015-3372-8

    Keywords

    Search

    Navigation